A Contemporary Review of Antiplatelet Therapies in Current Clinical Practice.

Publication date: Jul 05, 2023

Antiplatelet therapy plays a crucial role in a number of cardiovascular disorders. We currently have a range of antiplatelet agents in our armamentarium. In this review, we aim to summarise the common antiplatelet agents currently available, and their use in clinic practice. We not only highlight recent trials exploring antiplatelet therapy in atherosclerotic cardiovascular disease, but also in trials related to transcatheter aortic valve implantation and coronavirus disease 2019. Inevitably, the antithrombotic benefits of these drugs are accompanied by an increase in bleeding complications. Therefore, an individualised approach to weighing each patient’s thrombotic risk versus bleeding risk is imperative, in order to improve clinical outcomes.

Open Access PDF

Concepts Keywords
Armamentarium acute coronary syndrome
Cardiovascular antiplatelet therapy
Coronavirus atherosclerotic vascular disease
Drugs coronavirus 2019
Therapy ischaemic heart disease
peripheral vascular disease


Type Source Name
disease MESH cardiovascular disease
disease MESH coronavirus disease 2019
disease MESH bleeding
disease MESH complications
disease MESH vascular disease
disease MESH heart disease
disease MESH acute coronary syndrome
disease MESH stroke
disease MESH peripheral vascular disease
drug DRUGBANK Coenzyme M
disease VO dose
drug DRUGBANK Acetylsalicylic acid

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *